SCHEMBL6589174

SCHEMBL6589174

CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)OC(C)(C)C

nearest known ligand 0.64

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.64
CTSB P07858 2/20 0.64
CTSK P43235 2/20 0.64
PTPN1 P18031 1/20 0.55
MMP9 P14780 1/20 0.52
MMP8 P22894 1/20 0.52
GHSR Q92847 1/20 0.52
TACR1 P25103 12/20 0.51
ACE P12821 1/20 0.50
CACNA1B Q00975 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5552762 1.00 CTSS (0.64) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL7880090 0.93 CTSS (0.58) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL7880118 0.90 CTSS (0.55) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL6590575 0.89 CTSB (0.56) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL6590570 0.89 CTSB (0.56) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL8894210 0.89 CTSS (0.60) CTSSCTSBCTSKACECACNA1B
SCHEMBL7881440 0.87 PTPN1 (0.66) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL6595043 0.86 CTSB (0.55) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL6595039 0.86 CTSB (0.55) CTSSCTSBCTSKPTPN1MMP9
SCHEMBL6807031 0.85 CTSS (0.54) CTSSCTSBCTSKACECACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0830347-B1 NOVEL SUBSTITUTED PIPERAZINE DERIVATIVES HAVING TACHYKININ RECEPTOR ANTAGONISTS ACTIVITY AVENTIS PHARMA INC (US) 2004-09-22 EP disclosed
CN-1098255-C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity AVENTIS PHARMA INC (US) 2003-01-08 CN disclosed
CN-1083429-C Substituted alkyldiamine derivatives and their use as tachykinin antagonists MERRELL PHARMA INC (US) 2002-04-24 CN disclosed
EP-0767783-B1 SUBSTITUTED ALKYLDIAMINE DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERRELL PHARMA INC (US) 1998-08-19 EP disclosed
CN-1181753-A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity HOECHST MARION ROUSSEL INC (US) 1998-05-13 CN disclosed
EP-0830347-A1 NOVEL SUBSTITUTED PIPERAZINE DERIVATIVES HAVING TACHYKININ RECEPTOR ANTAGONISTS ACTIVITY HOECHST MARION ROUSSEL, INC. (US) 1998-03-25 EP disclosed
US-5672602-A Substituted piperazine derivatives HOECHST MARION ROUSSEL, INC. (US) 1997-09-30 US disclosed
CN-1155883-A Substituted alkyldiamine derivatives and their use as tachykinin antagonists MERRELL PHARMA INC (US) 1997-07-30 CN disclosed
EP-0767783-A1 SUBSTITUTED ALKYLDIAMINE DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1997-04-16 EP disclosed
US-5610140-A ANALGESICS, ANTIINFLAMMTORY AGENTS; TREATMENT OF ASTHMA CORTECH, INC. (US) 1997-03-11 US disclosed
US-5597845-A TACHYKININ ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1997-01-28 US disclosed
WO-1996032385-A1 NOVEL SUBSTITUTED PIPERAZINE DERIVATIVES HAVING TACHYKININ RECEPTOR ANTAGONISTS ACTIVITY HOECHST MARION ROUSSEL, INC. (US) 1996-10-17 WO disclosed
WO-1995035279-A1 SUBSTITUTED ALKYLDIAMINE DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1995-12-28 WO disclosed